Latest Breaking News On - Samsung bioepi - Page 4 : comparemela.com

Novartis Sandoz targets biosimilar version of J&J drug in Samsung deal

FRANKFURT (Reuters) -Novartis' generic-drugs unit Sandoz said on Monday it plans to launch a generic version of Johnson & Johnson's anti-inflammatory drug Stelara under a collaboration deal with Samsung Bioepis. For Sandoz, which is due to become an independent company early next month, the transaction means more investment in the growing market of biosimilars, which are lower-cost copies of complex biotech drugs that have lost patent protection.

United statesMiranda murraySamsung bioepiSamsung bioepisLudwig burgerMichael perryRichard saynorOhnson johnsonAnti inflammatory drugBiotech drugsClinical development

Health: Novartis Sandoz targets biosimilar version of J&J drug in Samsung deal

Health: Novartis Sandoz targets biosimilar version of J&J drug in Samsung deal
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United statesRichard saynorSamsung bioepiSamsung bioepis

Sandoz to commercialise mAb biosimilar candidate

Sandoz to commercialise mAb biosimilar candidate
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLendava lendvaSlovenia generalSamsung bioepiSamsung bioepisRichard saynorSandoz biopharma development centerSamsung bioepis co ltdAmerican academy of dermatologyPanaceum mediaJanssen pharmaceutical stelaraAmerican academyAnnual meeting

Samsung Bioepis considering takeover of Biogen s unit: reports

Samsung Bioepis is considering acquiring a biosimilar business unit of Biogen for around 1 trillion won ($775.3 million) to improve its presence in the US market, according to local reports on Wednesday. The acquisition will see Samsung Bioepis secure a direct sales network in the US, which could help it boost sales in the world's largest drug market. The reports on Samsung Bioepis’ potential acquisition c.

United statesCzech republicSamsung bioepisSamsung bioepi humiraSamsung bioepiDrug administrationShim woo hyunThe korea heraldOrean newsOuth korea newsOuth korea news in englishSia newsK pop코리아 헤럴드

Samsung Bioepis Said to Acquire U S Biogen s Biosimilar Unit

Samsung Bioepis Said to Acquire U S Biogen s Biosimilar Unit
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaUnited statesSamsung bioepiSamsung bioepisSamsung biologics coSamsung bioepis coSamsung groupBiogen incKorea bizwire